Skip to content
2000
Volume 14, Issue 1
  • ISSN: 1875-6921
  • E-ISSN: 1875-6913

Abstract

Drugs are generally tested on a large population of people via phase studies and the average response is reported in a sort of evidence-based medicine. Screening of genetic variations is necessary in understanding the underlying mechanisms of individual drug responses and to find out more targeted and unique therapeutic strategies focusing on this individual variations. The “-omics” (genomics/proteomics/metabolomics) technology can enable researchers to further understand the causative mechanisms/ biomarkers. Furthermore, they might be used to assess optimized drug efficacy and safety. The most common indications for traditional use of medicinal plants included gastrointestinal, urinary tract and gynecology, cough and cold, wound healing, pain and inflammation, and mental stress and mood disorders. The traditional use of these herbal medicines primarily incorporates a personalized approach and emphasis on prevention rather than a single disease targeted therapy with conventional mono-component drugs since these medicines have more than one component with multiple targets within the body. Therefore, because of the emphasis on individualization and prevention, the use of omics technology for precise or personalized approaches for medicinal plants is even more promising than it is for conventional medicines.

Loading

Article metrics loading...

/content/journals/cppm/10.2174/1875692115666161223164108
2016-06-01
2025-09-09
Loading full text...

Full text loading...

/content/journals/cppm/10.2174/1875692115666161223164108
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test